Osteoarthritis, Knee
Conditions
Keywords
osteoarthritis, pain, paracetamol, Blood-Oxygen-Level-Dependent functional magnetic resonance imaging
Brief summary
Blood-Oxygen-Level-Dependent (BOLD) responses to painful mechanical stimulation of the OA knee following treatment with four consecutive doses (at 8 hour intervals) on giving sustained released paracetamol treatment or placebo will be compared. The fMRI and pain assessments will occur approximately 2-5 hours after taking the final dose.
Detailed description
The objective of this study is to investigate if functional magnetic response imaging (fMRI) can detect the effects of a known pain medicine at over-the-counter doses in people with osteoarthritis (OA) of the knee. The fMRI is a harmless and painless technique that is used in the current study to collect images of brain activity to see if is changed when feeling pain. In this study, BOLD response to mechanical stimulation via pressure stimuli applied to the tibio-femoral joint and patello-femoral in participants with knee OA following four treatment doses of any of three treatment will be compared.
Interventions
665 mg sustained release paracetamol caplets
Placebo caplets
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosis of osteoarthritis of at least one knee for 3 months * Male or female at least 45 years of age * Score a minimum of 4 out of 10 on the numerical pain rating and a maximum of 8 at screening
Exclusion criteria
* If female, is pregnant, lactating, or breast feeding * Has secondary cause of knee arthritis * Lower extremity surgery in the last 6 months * Prior injury in the last twelve months to the index knee * Used any analgesics (NSAIDs, COX2 inhibitor, etc) within 5 half lives of study start * Recently used oral or injected glucocorticoids
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)] | Baseline to 2-5 hours post last dose administration | BOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)] | Baseline and post-dose before stimulus | Subjective NRS response for each participant was calculated as difference of pre-treatment NRS pain assessment before stimulus and post-treatment NRS pain assessment before stimulus. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine. |
| Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)] | Baseline and post-dose pre-scan after stimulus | Subjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on tibio-femoral joint. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine. |
| BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | Baseline to 2-5 hours post last dose administration | BOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution |
| Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)] | Baseline and post-dose post-scan after stimulus | Subjective NRS response for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on tibio-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine. |
| Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)] | Baseline and post-dose post-scan after stimulus | Subjective NRS response for each participant for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine. |
| Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)] | Baseline and post-dose pre-scan after stimulus | Subjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine. |
Countries
Spain
Participant flow
Recruitment details
Study was conducted at a single centre in Spain.
Pre-assignment details
Out of 33 screened participants, 31 were randomized, while 2 participants were considered as screen failures
Participants by arm
| Arm | Count |
|---|---|
| Total Participants for Baseline Measurement All randomized participants except one were evaluated for baseline measures. One participant had misallocated treatments that could not be determined. Therefore, this participant was excluded from all populations including safety. | 30 |
| Total | 30 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 |
|---|---|---|---|---|---|
| Period 1 | Adverse Event | 0 | 0 | 0 | 1 |
| Period 2 | Adverse Event | 1 | 0 | 0 | 0 |
| Period 3 | Protocol Violation | 0 | 2 | 0 | 0 |
Baseline characteristics
| Characteristic | Total Participants for Baseline Measurement |
|---|---|
| Age, Customized Years | 68.5 Years STANDARD_DEVIATION 7.97 |
| Sex: Female, Male Female | 26 Participants |
| Sex: Female, Male Male | 4 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — |
| other Total, other adverse events | 3 / 29 | 3 / 28 | 2 / 30 |
| serious Total, serious adverse events | 0 / 29 | 0 / 28 | 0 / 30 |
Outcome results
Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)]
BOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution.
Time frame: Baseline to 2-5 hours post last dose administration
Population: Intention-to-treat (ITT) population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Paracetamol 665 mg | Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)] | NA Z-score |
| Placebo | Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)] | NA Z-score |
| No Treatment | Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)] | NA Z-score |
BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]
BOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution
Time frame: Baseline to 2-5 hours post last dose administration
Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Frontal Cortex | NA Z-score | — |
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Sensory Cortex (a) | 0.16 Z-score | Standard Deviation 0.36 |
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Supramarginal Gyrus | 0.46 Z-score | Standard Deviation 0.48 |
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Thalamus | 0.48 Z-score | Standard Deviation 1.34 |
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Subgenu Prefrontal | NA Z-score | — |
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Insula | NA Z-score | — |
| Paracetamol 665 mg | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Sensory Cortex (b) | NA Z-score | — |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Subgenu Prefrontal | -0.27 Z-score | Standard Deviation 0.41 |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Sensory Cortex (b) | -0.11 Z-score | Standard Deviation 0.6 |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Sensory Cortex (a) | NA Z-score | — |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Thalamus | -0.68 Z-score | Standard Deviation 1.74 |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Insula | 0.12 Z-score | Standard Deviation 0.51 |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Supramarginal Gyrus | NA Z-score | — |
| Placebo | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Frontal Cortex | -0.04 Z-score | Standard Deviation 0.31 |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Supramarginal Gyrus | 0.76 Z-score | Standard Deviation 0.49 |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Thalamus | NA Z-score | — |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Sensory Cortex (b) | 0.44 Z-score | Standard Deviation 0.48 |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Subgenu Prefrontal | 0.19 Z-score | Standard Deviation 0.37 |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Frontal Cortex | 0.26 Z-score | Standard Deviation 0.42 |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Sensory Cortex (a) | 0.48 Z-score | Standard Deviation 0.48 |
| No Treatment | BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)] | BOLD - Insula | 0.62 Z-score | Standard Deviation 0.62 |
Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)]
Subjective NRS response for each participant for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Time frame: Baseline and post-dose post-scan after stimulus
Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Paracetamol 665 mg | Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)] | 0.30 Score on a Scale | Standard Deviation 1.66 |
| Placebo | Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)] | -0.48 Score on a Scale | Standard Deviation 1.62 |
| No Treatment | Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)] | -0.39 Score on a Scale | Standard Deviation 1.92 |
Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)]
Subjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Time frame: Baseline and post-dose pre-scan after stimulus
Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Paracetamol 665 mg | Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)] | 0.60 Score on a Scale | Standard Deviation 1.23 |
| Placebo | Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)] | 0.43 Score on a Scale | Standard Deviation 0.95 |
| No Treatment | Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)] | 0.00 Score on a Scale | Standard Deviation 0.91 |
Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)]
Subjective NRS response for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on tibio-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Time frame: Baseline and post-dose post-scan after stimulus
Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Paracetamol 665 mg | Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)] | 0.15 Score on a Scale | Standard Deviation 1.18 |
| Placebo | Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)] | 0.09 Score on a Scale | Standard Deviation 1.38 |
| No Treatment | Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)] | -0.13 Score on a Scale | Standard Deviation 1.1 |
Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)]
Subjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on tibio-femoral joint. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Time frame: Baseline and post-dose pre-scan after stimulus
Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Paracetamol 665 mg | Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)] | 0.55 Score on a Scale | Standard Deviation 0.89 |
| Placebo | Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)] | 0.17 Score on a Scale | Standard Deviation 1.07 |
| No Treatment | Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)] | 0.00 Score on a Scale | Standard Deviation 0.74 |
Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)]
Subjective NRS response for each participant was calculated as difference of pre-treatment NRS pain assessment before stimulus and post-treatment NRS pain assessment before stimulus. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Time frame: Baseline and post-dose before stimulus
Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Paracetamol 665 mg | Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)] | 0.95 Score on a Scale | Standard Deviation 1.67 |
| Placebo | Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)] | -0.52 Score on a Scale | Standard Deviation 1.53 |
| No Treatment | Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)] | 0.48 Score on a Scale | Standard Deviation 1.83 |